Nyere principper og muligheder inden for astmabehandling

Julie H Janner; Charlotte Suppli Ulrik

Nyere principper og muligheder inden for astmabehandling

1 Citationer (Scopus)

Abstract

In the coming years, asthma therapy should be tailored to the individual patient's needs. The principles of optimal asthma control and symptom-driven therapy offer the possibility for more individualised asthma management. Omalizumab (monoclonal anti IgE) may have positive clinical effects, including a reduction in the exacerbation-rate, and is indicated for patients, who--in spite of best possible asthma therapy--continue to have reduced lung function, severe exacerbations, severe symptoms, and documented non-seasonal allergy.

Bidragets oversatte titel	New principles and possibilities in the treatment of asthma
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	169
Udgave nummer	11
Sider (fra-til)	995-7
Antal sider	3
ISSN	0041-5782
Status	Udgivet - 2007

Citationsformater

@article{249b26ce6cac4cdd8581844c09bd4d0e,

title = "Nyere principper og muligheder inden for astmabehandling",

abstract = "In the coming years, asthma therapy should be tailored to the individual patient's needs. The principles of optimal asthma control and symptom-driven therapy offer the possibility for more individualised asthma management. Omalizumab (monoclonal anti IgE) may have positive clinical effects, including a reduction in the exacerbation-rate, and is indicated for patients, who--in spite of best possible asthma therapy--continue to have reduced lung function, severe exacerbations, severe symptoms, and documented non-seasonal allergy.",

author = "Janner, {Julie H} and Ulrik, {Charlotte Suppli}",

year = "2007",

language = "Dansk",

volume = "169",

pages = "995--7",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "11",

}

TY - JOUR

T1 - Nyere principper og muligheder inden for astmabehandling

AU - Janner, Julie H

AU - Ulrik, Charlotte Suppli

PY - 2007

Y1 - 2007

N2 - In the coming years, asthma therapy should be tailored to the individual patient's needs. The principles of optimal asthma control and symptom-driven therapy offer the possibility for more individualised asthma management. Omalizumab (monoclonal anti IgE) may have positive clinical effects, including a reduction in the exacerbation-rate, and is indicated for patients, who--in spite of best possible asthma therapy--continue to have reduced lung function, severe exacerbations, severe symptoms, and documented non-seasonal allergy.

AB - In the coming years, asthma therapy should be tailored to the individual patient's needs. The principles of optimal asthma control and symptom-driven therapy offer the possibility for more individualised asthma management. Omalizumab (monoclonal anti IgE) may have positive clinical effects, including a reduction in the exacerbation-rate, and is indicated for patients, who--in spite of best possible asthma therapy--continue to have reduced lung function, severe exacerbations, severe symptoms, and documented non-seasonal allergy.

M3 - Tidsskriftartikel

SN - 0041-5782

VL - 169

SP - 995

EP - 997

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 11

ER -

Nyere principper og muligheder inden for astmabehandling

Abstract

Fingeraftryk

Citationsformater